Product Information

CARBAMAZEPINE ER 100 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1989 per EA under NDC 62135092760. Its NADAC has been published 65 times since May 28, 2025.

FDA first approved this application on Mar 31, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE ER 100 MG TABLET

Carbamazepine ER
$0.1989per EA

Strength

100 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135092760

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA215591

FDA Approved

3/31/2022

TE Code

AB

On Market Since

3/31/2022

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE ER 100 MG TABLET has been published 65 times since May 28, 2025, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1989 per EA
All-time high$0.2610 (Nov 12, 2025)
All-time low$0.1989 (Aug 19, 2026)
52-week high$0.2610
52-week low$0.1989
Median price$0.2455
Average price$0.2419
Largest weekly change-7.8% (Jan 21, 2026)
Weeks tracked65
Tracking sinceMay 28, 2025

Price History

1W

-6.8%

1M

-6.8%

3M

-15.1%

6M

-13.9%

1Y

-20.9%

3Y

N/A

5Y

N/A

All

-19.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Carbamazepine ER market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE ER 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 100 MG TABLET, manufactured by Chartwell RX LLC, is $0.1989 per EA (NDC 62135092760), effective Aug 19, 2026.

How has the price of CARBAMAZEPINE ER 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE ER 100 MG TABLET has declined 19.6%. It has been tracked across 65 weekly CMS publications since May 28, 2025.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 100 MG TABLET?

Since May 28, 2025, the NADAC for CARBAMAZEPINE ER 100 MG TABLET has ranged from a low of $0.1989 (Aug 19, 2026) to a high of $0.2610 (Nov 12, 2025), with a median of $0.2455 per EA.

Are there cheaper alternatives to CARBAMAZEPINE ER 100 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of CARBAMAZEPINE ER 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CARBAMAZEPINE ER 100 MG TABLET?

CARBAMAZEPINE ER 100 MG TABLET (NDC 62135092760) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.